Related Experiment Video
Updated: Mar 29, 2026
Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
The role of mechano-growth factor E peptide in the regulation of osteosarcoma
Jin Shang1, Xin Fan1, Huan Liu1
1Department of Orthopedics, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R. China.
Abstract:
Osteosarcoma is one of the most common bone tumors, and exhibits a high degree of malignancy. Gene therapy is a novel approach to its treatment, however, specific target genes are required to enable effective use of this therapy. In order to investigate the effects of the mechano-growth factor E (MGF-E) peptide, which is derived from the IGF-I alternative splicing isoform, on the regulation of the development of osteosarcoma, the expression of MGF was detected in osteosarcoma cell lines with different degrees of malignancy. Concomitantly, exogenous MGF-E peptide was used to stimulate these osteosarcoma cell lines. The results demonstrated that MGF was overexpressed in malignant osteosarcoma cells, while it was not expressed in the least malignant osteosarcoma cells. Furthermore, MGF-E treatment altered the cell cycle distribution, and promoted the proliferation, migration and invasion of osteosarcoma cells. The possible mechanisms underlying these effects were detected by quantitative polymerase chain reaction and western blotting. Based on these results, it was hypothesized that MGF may be a suitable biomarker for malignant osteosarcoma phenotypes.
Insights
Mechano-growth factor E (MGF-E) is overexpressed in malignant osteosarcoma cells. This peptide promotes osteosarcoma cell proliferation, migration, and invasion, suggesting its potential as a biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma is a highly malignant bone tumor.
- Gene therapy offers a novel treatment approach for osteosarcoma, necessitating identification of specific target genes.
- Mechano-growth factor (MGF), an IGF-I splice variant, plays a role in cell growth and development.
Purpose of the Study:
- To investigate the role of MGF-E peptide in osteosarcoma development.
- To determine MGF expression levels in osteosarcoma cell lines with varying malignancy.
- To assess the impact of exogenous MGF-E on osteosarcoma cell behavior.
Main Methods:
- Detection of MGF expression in osteosarcoma cell lines.
- Stimulation of cell lines with exogenous MGF-E peptide.
- Analysis of cell cycle distribution, proliferation, migration, and invasion.
- Quantitative polymerase chain reaction and western blotting to elucidate underlying mechanisms.
Main Results:
- MGF was significantly overexpressed in highly malignant osteosarcoma cells compared to less malignant ones.
- MGF-E peptide treatment enhanced osteosarcoma cell proliferation, migration, and invasion.
- Alterations in cell cycle distribution were observed following MGF-E treatment.
Conclusions:
- MGF is overexpressed in malignant osteosarcoma, correlating with higher malignancy.
- MGF-E peptide promotes key oncogenic behaviors in osteosarcoma cells.
- MGF may serve as a valuable biomarker for identifying malignant osteosarcoma phenotypes.
Related Concept Videos
02:38Mitogens and the Cell Cycle
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:16TGF - β Signaling Pathway
01:24Regulation of Angiogenesis and Blood Supply
01:28Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...